1/7/2024 0 Comments Netspot novartis![]() These symptoms may include flushing, diarrhea, difficulty breathing (bronchospasm), and low blood pressure (hypotension), and may occur during or within the 24 hours after your first LUTATHERA treatment. Hormonal gland problems (carcinoid crisis): During your treatment you may experience certain symptoms that are related to hormones released from your cancer.Symptoms may include trouble breathing or swallowing raised bumps (hives) rash or itching and swelling of the face, lips, tongue, throat, or arms. Seek emergency help right away for any serious allergic reactions. Notify your health care provider if you develop symptoms of an allergic reaction. Allergic reactions: Allergic reactions have occurred in people who were treated with LUTATHERA.Your health care provider will monitor your liver using blood tests and may need to withhold, reduce, or stop your LUTATHERA treatment accordingly. Signs that you may be experiencing liver damage include increases in blood markers called alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase. If you have tumors in your liver, you may be more likely to experience these side effects. Liver problems: In clinical studies of LUTATHERA, less than 1% of patients were reported to have tumor bleeding (hemorrhage), swelling (edema), or tissue damage (necrosis) to the liver.Your doctor will monitor your kidney function and may withhold, reduce, or stop your LUTATHERA treatment accordingly. You should urinate frequently during and after administration of LUTATHERA. You should stay well hydrated before, during, and after your treatment. ![]() Your health care provider will provide you with an amino acid solution before, during, and after LUTATHERA to help protect your kidneys. In some cases, patients have experienced kidney failure after treatment with LUTATHERA. You may be at an increased risk for kidney problems after LUTATHERA treatment if you already have kidney impairment before treatment. Kidney problems: Treatment with LUTATHERA will expose your kidneys to radiation and may impair their ability to work as normal.Your health care provider will routinely check your blood cell counts and tell you if they are too low or too high. Secondary bone marrow and blood cancers: Other serious conditions that you may develop as a direct result of treatment with LUTATHERA include blood and bone marrow disorders known as secondary myelodysplastic syndrome and cancer known as acute leukemia.Your health care provider may need to adjust or stop your treatment accordingly. Speak with your health care provider if you experience any signs or symptoms of infection, fever, chills, dizziness, shortness of breath, or increased bleeding or bruising. You may experience blood-related side effects such as low red blood cells (anemia), low numbers of cells that are responsible for blood clotting (thrombocytopenia), and low numbers of white blood cells (neutropenia). Bone marrow problems: Treatment with LUTATHERA increases the risk of myelosuppression, a condition in which bone marrow activity is decreased, resulting in a drop in blood cell counts.It is important to minimize radiation exposure to household contacts consistent with good radiation safety practices as advised by your health care provider. The radiation will be detectable in your urine for up to 30 days following administration of the drug. Overall radiation exposure is associated with an increased risk for cancer. Radiation exposure: Treatment with LUTATHERA will expose you to radiation, which can contribute to your long-term radiation exposure.You should always follow your health care provider’s instructions. ![]() LUTATHERA is associated with some serious safety considerations and, in some cases, these may require your health care provider to adjust or stop your treatment. What are some important things to know about the safety of LUTATHERA?
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |